Clinical Trials Directory

Trials / Unknown

UnknownNCT01609712

Osteoporotic Vertebral Compression Fractures: Can Kyphoplasty Improve Lung Function? A Prospective Evaluation

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
University Hospital, Bonn · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

Patients with vertebral fractures often have problems to straighten and as a consequence of impaired lung ventilation that leads to a impaired lung function. Furthermore, it comes to the sintering of the vertebra and a so-called hunchback. This also contributes to the poorer expansion of the lung. Pain is also caused by respiratory excursions of the chest which hinder the patients to use their entire lung volume. Kyphoplasty is designed to counter all these consequences of vertebral fractures by bringing stability to the fracture. In order to prove the thesis the results of lung function test (FEV1, PEF) are assessed.

Conditions

Interventions

TypeNameDescription
PROCEDURERadiofrequency KyphoplastyRadiofrequency kyphoplasty is a new form of surgical treatment. It injects an ultrahigh viscosity cement into the fractured vertebral body, using radiofrequency to achieve the proper consistency of the cement. This ultrahigh viscosity cement is designed to first restore proper height and alignment to the fractured vertebra and then to stabilize the fracture, thereby preventing further intravertebral motion and reducing pain. The RF-Kyphoplasty is standard of care in our hospital. It is FDA and CE approved.

Timeline

Start date
2012-05-01
First posted
2012-06-01
Last updated
2012-06-05

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01609712. Inclusion in this directory is not an endorsement.

Osteoporotic Vertebral Compression Fractures: Can Kyphoplasty Improve Lung Function? A Prospective Evaluation (NCT01609712) · Clinical Trials Directory